Precision Medicine News and Research

RSS

Gentris expands genomic biomarker offering with launch of Affymetrix GeneChip HTA services

Gentris Corporation, a global leader in pharmacogenomics and biorepository solutions, announced today that it is expanding its genomic biomarker offering with the launch of Affymetrix GeneChip Human Transcriptome Array services.

17 Sep 2013

Studying Tumor Mutations Via A Network Approach

...

16 Sep 2013

New approach subtypes cancers by shared genetic effects; a step toward personalized medicine

Cancer tumors almost never share the exact same genetic mutations, a fact that has confounded scientific efforts to better categorize cancer types and develop more targeted, effective treatments.

16 Sep 2013

Data can help scientists, physicians match precision drugs to cancer's genetic traits

More than 5,000 genetic profiles of tumor DNA have been completed in a large research study by scientists at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Boston Children's Hospital designed to speed the development of personalized cancer care with precision treatments.

13 Sep 2013

NIH budget slashing may stall future pain research funding

Multi-faceted pain research discoveries within the last decade are bringing new hope for the estimated 100 million Americans with chronic pain. Unfortunately, translation of these scientific advances into clinical practice could be stalled without sufficient funding for both basic science and clinical pain research, according to the American Pain Society.

12 Sep 2013

Current criteria for ALK positive lung cancer needs to be redefined

A University of Colorado Cancer Center study published today in the journal Cancer shows that the current criteria used to match lung cancers with the drug crizotinib may miss some patients who could benefit from the drug. The findings suggest that doctors should look closer at borderline or atypical ALK-negative cases, and could widen the population of lung cancer patients offered treatment with crizotinib or other ALK-inhibitor drugs.

12 Sep 2013

Mount Sinai physician-scientists join DILIN to help find causes, diagnostics for drug-induced liver injury

In an effort to better understand and develop prevention strategies for drug-induced liver injury, physician-scientists from the Icahn School of Medicine at Mount Sinai have joined the Drug-Induced Liver Injury Network, a National Institutes of Health-funded consortium of only six academic medical centers in the United States.

12 Sep 2013

Bayer, Broad On Five-Year Mission To Search For Novel Cancer Therapeutics

...

10 Sep 2013

Banook Central Imaging, Oncodesign partner to expand use of new approaches in pharmaco-imaging

Oncodesign, a contract research laboratory dedicated to the discovery of new anticancer therapies, and Banook Central Imaging, a company specializing in the centralized reading of medical images, today announce the start of a partnership to expand the use of new approaches in pharmaco-imaging.

10 Sep 2013

Viewpoints: Administration is 'fighting back' on Obamacare; Democrats' 'nervous breakdown' about GOP inquiry on navigators

In Washington, Republican members of the House Committee on Energy and Commerce have sent intimidating letters to many of the groups hired as navigators, demanding all their paperwork and suggesting that the groups intend to exploit the work for fund-raising or political purposes.

7 Sep 2013

Endocyte, Nihon Medi-Physics Collaborate On Companion Imaging Diagnostic

...

6 Sep 2013

Endocyte, Nihon Medi-Physics Collaborate On Companion Imaging Diagnostic

...

6 Sep 2013

Bioinformatics researchers investigate functional diversity of proteins

No two human beings are the same. Although we all possess the same genes, our genetic code varies in many places. And since genes provide the blueprint for all proteins, these variants usually result in numerous differences in protein function. But what impact does this diversity have? Bioinformatics researchers at Rutgers University and the Technische Universitaet Muenchen have investigated how protein function is affected by changes at the DNA level.

6 Sep 2013

Scientists identify enzyme mutation that occurs in castration-resistant prostate cancer

The mutation occurs in the androgen-synthesizing enzyme 3βHSD1 in castration-resistant prostate cancer (CRPC), according to research published online today in Cell. This mutation enables the tumor to make its own supply of androgens, a hormone that fuels the growth of the prostate cancer.

30 Aug 2013

Companion diagnostics: an interview with Trevor Hawkins, SVP, Strategy, Innovation and Business Development for Siemens Healthcare Diagnostics

Companion diagnostics is critical in helping to pave the way for personalized medicine, in which the treatment is adapted and precisely tailored to the patient.

From Siemens Healthineers 27 Aug 2013

Vanderbilt adds genetic screening for drug tacrolimus to PREDICT program

Vanderbilt has added genetic screening for the drug tacrolimus to its personalize medicine pharmacogenomics program PREDICT. The new drug screening protocol was added following data that shows a single genetic variation largely impacts different dose requirements for patients.

27 Aug 2013

Tufts Health Plan provides positive coverage decision and in-network provider status to bioTheranostics

bioTheranostics, a leading provider of molecular diagnostic solutions for cancer, has received a positive coverage decision and in-network provider status from Tufts Health Plan for its CancerTYPE ID molecular cancer classifier.

23 Aug 2013

Mount Sinai, Exosome Partner On Body Fluid Molecular Diagnostics

...

22 Aug 2013

Genenews Axes 60% Of Staff To Boost New JV

...

22 Aug 2013

Caris Life Sciences to facilitate patient access to tumour profiling service in Middle East and Africa

Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of personalized medicine in oncology, has signed a distribution agreement with IPS Genomix to facilitate patient access to its tumour profiling service, Molecular Intelligence, in select Middle Eastern and African markets.

22 Aug 2013

Precision Medicine News and Research

Gentris expands genomic biomarker offering with launch of Affymetrix GeneChip HTA services

Studying Tumor Mutations Via A Network Approach

New approach subtypes cancers by shared genetic effects; a step toward personalized medicine

Data can help scientists, physicians match precision drugs to cancer's genetic traits

NIH budget slashing may stall future pain research funding

Current criteria for ALK positive lung cancer needs to be redefined

Mount Sinai physician-scientists join DILIN to help find causes, diagnostics for drug-induced liver injury

Bayer, Broad On Five-Year Mission To Search For Novel Cancer Therapeutics

Banook Central Imaging, Oncodesign partner to expand use of new approaches in pharmaco-imaging

Viewpoints: Administration is 'fighting back' on Obamacare; Democrats' 'nervous breakdown' about GOP inquiry on navigators

Endocyte, Nihon Medi-Physics Collaborate On Companion Imaging Diagnostic

Endocyte, Nihon Medi-Physics Collaborate On Companion Imaging Diagnostic

Bioinformatics researchers investigate functional diversity of proteins

Scientists identify enzyme mutation that occurs in castration-resistant prostate cancer

Companion diagnostics: an interview with Trevor Hawkins, SVP, Strategy, Innovation and Business Development for Siemens Healthcare Diagnostics

Vanderbilt adds genetic screening for drug tacrolimus to PREDICT program

Tufts Health Plan provides positive coverage decision and in-network provider status to bioTheranostics

Mount Sinai, Exosome Partner On Body Fluid Molecular Diagnostics

Genenews Axes 60% Of Staff To Boost New JV

Caris Life Sciences to facilitate patient access to tumour profiling service in Middle East and Africa

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News